Clinical stage Tlc prostate cancer: Pathologic outcomes following radical prostatectomy in black and white men Academic Article uri icon

Overview

MeSH Major

  • African Continental Ancestry Group
  • European Continental Ancestry Group
  • Prostatic Neoplasms

abstract

  • Racial differences in the incidence and mortality rate of prostate cancer are well known, but differences in the clinical and pathologic features between black and white men with prostate cancer identified solely based on an elevated serum PSA level with negative results on digital rectal examination (clinical stage T1c ) have been poorly studied. Our results suggest that men with clinical stage T1c prostate cancer have similar clinical and pathologic findings regardless of race. These results suggest that early-detection programs using serum PSA testing for prostate cancer in black men potentially can result in improvements in prostate cancer outcomes in this high-risk group.

publication date

  • March 11, 2002

Research

keywords

  • Academic Article

Identity

Language

  • eng

Digital Object Identifier (DOI)

  • 10.1002/pros.10055

PubMed ID

  • 11870801

Additional Document Info

start page

  • 236

end page

  • 40

volume

  • 50

number

  • 4